Inhibition of MYC by the SMARCB1 tumor suppressor
SMARCB1/SNF5 is a tumour suppressor and component of the SWI/SNF chromatin remodeler. Here the authors show that, independent of chromatin remodelling activities, SNF5 acts to inhibit the pro-tumorigenic transcriptional program of MYC via control of RNA polymerase pause release at MYC target genes.
Guardado en:
Autores principales: | April M. Weissmiller, Jing Wang, Shelly L. Lorey, Gregory C. Howard, Ernest Martinez, Qi Liu, William P. Tansey |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/13320eef54514e9293ebfcb6fc8bf6ca |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development
por: Jeremie Vitte, et al.
Publicado: (2017) -
Genomic characterisation of Eμ-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene
por: Marcus Lefebure, et al.
Publicado: (2017) -
SMARCB1 deletion in atypical teratoid rhabdoid tumors results in human endogenous retrovirus K (HML-2) expression
por: Tara T. Doucet-O’Hare, et al.
Publicado: (2021) -
SMARCB1(INI1)-deficient undifferentiated carcinoma with rhabdoid features of anorectal origin
por: Hanan Dihowm, et al.
Publicado: (2021) -
Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition
por: Lei Gao, et al.
Publicado: (2019)